Assenagon Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $804K | Sell |
106,380
-6,292
| -6% | -$47.6K | ﹤0.01% | 929 |
|
|
2025
Q1 | $622K | Sell |
112,672
-80,184
| -42% | -$443K | ﹤0.01% | 963 |
|
|
2024
Q4 | $1.11M | Buy |
192,856
+49,050
| +34% | +$282K | ﹤0.01% | 1062 |
|
|
2024
Q3 | $1.49M | Sell |
143,806
-282,755
| -66% | -$2.93M | ﹤0.01% | 1014 |
|
|
2024
Q2 | $5.53M | Sell |
426,561
-157,097
| -27% | -$2.04M | 0.01% | 586 |
|
|
2024
Q1 | $10.2M | Hold |
583,658
| – | – | 0.02% | 399 |
|
|
2023
Q4 | $5.49M | Sell |
583,658
-47,968
| -8% | -$451K | 0.01% | 579 |
|
|
2023
Q3 | $7.06M | Buy |
631,626
+543,111
| +614% | +$6.07M | 0.02% | 453 |
|
|
2023
Q2 | $1.89M | Sell |
88,515
-29,842
| -25% | -$639K | 0.01% | 773 |
|
|
2023
Q1 | $4.79M | Buy |
118,357
+65,946
| +126% | +$2.67M | 0.02% | 571 |
|
|
2022
Q4 | $2.44M | Buy |
52,411
+29,353
| +127% | +$1.37M | 0.01% | 714 |
|
|
2022
Q3 | $1.2M | Sell |
23,058
-114,208
| -83% | -$5.92M | ﹤0.01% | 866 |
|
|
2022
Q2 | $6.49M | Buy |
137,266
+2,080
| +2% | +$98.3K | 0.02% | 456 |
|
|
2022
Q1 | $9.62M | Buy |
135,186
+23,703
| +21% | +$1.69M | 0.03% | 350 |
|
|
2021
Q4 | $8.34M | Buy |
111,483
+16,334
| +17% | +$1.22M | 0.02% | 346 |
|
|
2021
Q3 | $5.41M | Buy |
95,149
+78,792
| +482% | +$4.48M | 0.02% | 377 |
|
|
2021
Q2 | $720K | Buy |
+16,357
| New | +$720K | ﹤0.01% | 927 |
|
|
2020
Q4 | – | Sell |
-136,204
| Closed | -$6.24M | – | 1037 |
|
|
2020
Q3 | $6.24M | Buy |
136,204
+87,381
| +179% | +$4M | 0.04% | 248 |
|
|
2020
Q2 | $2.45M | Buy |
+48,823
| New | +$2.45M | 0.02% | 520 |
|